3 results for author:"Petrassi H.M." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. Tully D.C., Vidal A., Chatterjee A.K., Williams J.A., Roberts M.J., Petrassi H.M., Spraggon G., Bursulaya B., Pacoma R., Shipway A. et al. Bioorg. Med. Chem. Lett. 18:5895-5899(2008) · Mapped (1) |
| An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Jiang X., Smith C.S., Petrassi H.M., Hammarstroem P., White J.T., Sacchettini J.C., Kelly J.W. Biochemistry 40:11442-11452(2001) · UniProtKB (1) |
| Rational design of potent human transthyretin amyloid disease inhibitors. Klabunde T., Petrassi H.M., Oza V.B., Raman P., Kelly J.W., Sacchettini J.C. Nat. Struct. Biol. 7:312-321(2000) · UniProtKB (1) |